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The expression and glycosylation patterns of anti-colorectal cancer therapeutic
monoclonal antibody (mAb) CO17-1A recognizing the tumor-associated antigen
GA733-2, expressed in human colorectal carcinoma cells, were observed in the leaf
and stem tissues of primary (0 cycle), secondary (1 cycle), and tertiary (2 cycle) growths
of seedlings obtained from the stem cut of T2 plants. The bottom portion of the stem
of T2 seedlings was cut to induce the 1 cycle shoot growth, which was again cut to
induce the 2 cycle shoot growth. In the 1 and 2 cycle growths, the periods for floral
organ formation (35 days) was shorter than that (100 days) for the 0 cycle growth. The
genes of heavy and light chains of mAb CO17-1A existed at the top, middle, and basal
portions of the leaves and stem obtained from the 0, 1, and 2 cycle plants. The protein
levels in the leaves and stem tissues from the 1 and 2 cycles were similar to those in the
tissues from the 0 cycle. The glycosylation level and pattern in the leaf and stem did not
alter dramatically over the different cycles. Surface plasmon resonance (SPR) confirmed
that mAbs CO17-1A obtained from leaf and stem tissues of the 0, 1, and 2 cycles
had similar binding affinity for the GA733-2 antigen. These data suggest that the shoot
growth by bottom stem cutting is applicable to speed up the growth of plant biomass
expressing anti-colorectal cancer mAb without variation of expression, glycosylation,
and functionality.
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BACKGROUND
Plants are well recognized as alternative hosts for production of highly valuable recombinant
proteins, such as antibodies, vaccines, human blood products, hormones, and growth regulators
(Fernandez-San Millan et al., 2003; Rigano and Walmsley, 2005; Schillberg et al., 2013). They offer
mass production and safety advantages, with ease of seed storage, compared to the microbial and
animal cell-based systems (Twyman et al., 2003; Fischer et al., 2013; Shanmugaraj and Ramalingam,
2014). Plant cultivation can easily be modulated in response to the demand for the recombinant
protein by controlling the number of seeds sown (Fischer and Emans, 2000; Leckie and Stewart,
2011). The speed of obtaining plant biomass is essential in the application to save time for
production of recombinant proteins. In general, however, more than 14 weeks are required for
the development of a fully grown tobacco plant from the time of sowing of its seeds (Lim et al.,
2015). A plant-based recombinant protein production system might have drawbacks, such as
relatively long cultivation period for obtaining full biomass from the seeds, especially when there is
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time-constraint for use of the field for cultivation of such
plants. Therefore, rapid enhancement of the plant biomass is
imperative for increasing the efficiency of plant-based systems for
production of recombinant proteins.
Physiological mechanisms responsible for rapid growth of
lateral shoots, without a corresponding increase in root growth,
can promote biomass accumulation (Vysotskaya, 2005). Auxin,
an important hormone of shoots, in particular, regulates apical
dominance (Cline et al., 1997; Teale et al., 2006). The lower
lateral buds can be induced by cutting the terminal bud to
remove apical dominance (Skoog and Thimann, 1934; Leyser,
2003; Umehara et al., 2008). Moreover, the speed of plant shoot
growth could be enhanced by lowering the shoot/root ratio
(Vysotskaya, 2005), to overcome the space and time limitations.
The cutting of lower branches could be a strategy for plant
recycling system to speed up the biomass production without
the need for further sowing of seeds. In this study, the effect of
cutting the stem to remove apical dominance on shoot growth
rate was determined. Furthermore, the expression, glycosylation,
and function of a recombinant anti-colorectal cancer monoclonal
antibody (mAb) CO17-1A, expressed in the newly induced
shoots was determined to confirm whether secondary shoot
growth would be applicable as a plant recycling system to obtain
increased biomass for enhanced production of recombinant anti-
cancer mAb proteins.
MATERIALS AND METHODS
Plant Material and Cultivation
Forty seeds of transgenic tobacco T2 plants, with plant-
derived anti-colorectal cancer mAb (mAbP CO17-1A)
production capability (So et al., 2012), were sown in pots
(18.5 cm × 18.5 cm × 14.5 cm) filled with steam-sterilized
commercial soil mixture (Sun Gro Horticulture, Agawam,
MA; Figure 1A), respectively. Forty seedlings were grown in
greenhouse under simulated natural light conditions with an
average 12 h light/12 h dark photoperiod. The growth of plants
was measured immediately before flowering. The lower branch
of the primary plant seedling (0 cycle) was cut to induce axillary
buds for growth of lateral branches (1 cycle) on the remnant
10 cm long base stem (Figure 1A). The base stem of the 0 cycle
plant in the pot was maintained to induce the 1 cycle for the
growth of lateral branches until the appearance of inflorescence
on the shoot obtained from the axillary bud (Figure 1A). The
growth of tertiary (2 cycle) shoots was induced from the cut stem
of the fully grown l cycle plant (Figure 1A).
Polymerase Chain Reaction (PCR)
Amplification from Genomic DNA of Leaf
and Stem in 0, 1, and 2 Cycle Plants
Genomic DNA was isolated from approximately 100 mg of
leaf and stem tissues from the plants (0, 1, and 2 cycles) using
DNeasy kit (Qiagen, Hilden, Germany), according to the
manufacturer’s recommendations. The extracted DNA was
amplified by polymerase chain reaction (PCR) to confirm the
presence of genes for mAb CO17-1A heavy chain (HC; 1,471 bp)
and light chain (LC; 764 bp), by using the following forward and
reverse primers: HC forward primer, 5′-GCGAATTCATGGAA
TGGAGCAGAGTCTTTAT C-3′; HC reverse primer, 5′-GATTA
ATCGATTTTACCCGGAGTCCG-3′; LC forward primer, 5′-GC
CTCG AGATGGGCATCAAGATGGAATCACAG-3′; LC reverse
primer, 5′-GAGGTACCCTAACACTCATTCCTGTTGAAGCTC-
3′.
Western Blot Analysis
Eighty milligram of fresh leaves and stems (from top, middle,
and basal portions of plants) was crushed by cryo-milling to
extract the total soluble proteins. The homogenized plant samples
were mixed with 280 µL of sample buffer (1 M Tris-HCl, 50%
glycerol, 10% SDS, 5% 2-mercaptoethanol, 0.1% bromophenol
blue), and the homogenates were loaded on a sodium dodecyl
sulfate polyacrylamide gel. The electrophoresed proteins were
transferred on to a nitrocellulose membrane (Millipore Corp.,
Billerica, MA, USA), which was blocked with 5% skimmed milk
(Sigma, St. Louis, MO, USA), prepared in 1× phosphate-buffered
saline (PBS), for 2 h. The blot was subsequently probed with
goat anti-murine IgG Fcγ and anti-murine IgG F(ab)′2, which
recognize the HC and LC of mAb CO17-1A, respectively. The
purified mAbP CO17-1A was used as a positive control (Ko et al.,
2005).
Purification of Recombinant mAbP
CO17-1AK from Leaf and Stem of Plant
from Each Cycle
For purification of mAbP CO17-1AK, the leaves and stem from
the tobacco plants of the 0, 1, and 2 cycles were homogenized on
ice in the extraction buffer (37.5 mM Tris-HCl pH 7.5, 50 mM
NaCl, 15 mM EDTA, 75 mM sodium citrate, and 0.2% sodium
thiosulfate) using a blender. After centrifugation at 8,800 × g for
30 min at 4◦C, the supernatant was filtered through a Miracloth
(Biosciences, La Jolla, CA, USA), and its pH was adjusted to
5.1 with acetic acid. The supernatant was further centrifuged
at 10,200 × g for 30 min. The pH of the supernatant, thus
obtained, was adjusted to neutral by addition of 3 M Tris-
HCl. The total soluble protein was precipitated with ammonium
sulfate after overnight incubation in a cold room followed by
centrifugation at 4◦C for 30 min. The pellet was resuspended
in one-tenth of the starting volume of extraction buffer, and the
obtained solution was centrifuged at 10,200 × g for 30 min at
4◦C (Park et al., 2015). The mAbP CO17-1A protein was purified
using protein A Sepharose 4 Fast Flow (GE Healthcare, Sweden,
NJ, USA), according to the manufacturer’s recommendations.
The mAbP CO17-1A protein was dialyzed against 1× PBS (pH
7.4). The protein concentration was determined using a Nano-
drop (Biotek, Highland, VT, USA) and the purified protein was
visualized by SDS-PAGE. Aliquots of the purified protein were
stored at−80◦C for further studies.
Glycan Analysis
The purified mAbP CO17-1A protein samples were treated
twice with 1 µL pepsin in an incubator at 37◦C for 16 h to
Frontiers in Plant Science | www.frontiersin.org 2 July 2016 | Volume 7 | Article 1037
fpls-07-01037 July 15, 2016 Time: 15:7 # 3
Kim et al. Plant-Derived Therapeutic Monoclonal Antibody
FIGURE 1 | Continued
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FIGURE 1 | Continued
Schematic diagram for the primary (0 cycle), secondary (1 cycle), and tertiary (2 cycle) growth of plants expressing the anti-colorectal cancer
mAb CO17-1A. (A) Schematic diagram showing primary (0 cycle), secondary (1 cycle), and tertiary (2 cycle) growths from T0 transgenic plants. The base
stem of 0 cycle plant was cut to induce axillary buds for secondary plant growth (1 cycle), and the base stem of the 1 cycle plant was cut for the tertiary
plant growth (2 cycle). T, top of the whole plant; M, middle of the whole plant; B, base of the whole plant. (B) Comparison of plant growth period for
flowering in 0, 1, and 2 cycles. The growth of 0 cycle plants was compared with 1 and 2 cycle plants obtained from base stem cutting. The asterisks
indicate statistically significant differences (∗∗p < 0.01). (C) PCR analysis to confirm the existence of HC and LC genes in top, middle, and basal portions
of both the leaves and stems of transgenic plant (0, 1, and 2 cycles). The genomic DNA fragments of mAbP CO17-1A were amplified and
electrophoretically separated on a 1% agarose gel. NT, non-transgenic plant; HC, heavy chain of mAbP CO17-1A; LC, light chain of mAbP CO17-1A. (D,E)
Western blot analysis to confirm the mAbP CO17-1A HC and LC expression in the leaves and stems of transgenic plants through 0, 1, and 2 cycles. The
bands for HC (50 kDa) and LC (25 kDa) were detected with horse radish peroxidase-conjugated goat anti-mouse Fc and goat anti-mouse F(ab)′2-specific
antibody, respectively. +, purified mAb CO17-1A from plant (So et al., 2012); Top, top portion of plant; Middle, middle portion of plant; Base, basal portion
of plant (A).
digest the protein into glycopeptides. The glycopeptides were
collected using a C18 Sep-Pak cartridge (Waters, Lexington,
MA, USA). The N-glycosidase (PNGase) A glycan enzyme was
added to the collected glycopeptides to release the N-glycans,
and the mixtures were incubated overnight at 37◦C. The released
N-glycans were purified from the samples by using a graphitized
carbon resin from Carbograph (Alltech, Lexington, MA, USA).
The purified glycans were 2-aminobenzamide (2-AB)-labeled
using previously described methods (Bigge et al., 1995). The 2-
AB-labeled glycans were separated on a TSK amide-80 column
(5 µm, 4.6 mm × 250 mm; Tosoh Bioscience, Prussia, PA, USA)
using a high performance liquid chromatography (HPLC) system
with a fluorescence detector (330 nm excitation and 425 nm
emission; Lim et al., 2015). The separation of the labeled glycans
was achieved at a flow rate of 1.0 mL/min using a mixture of
solvent A (100% acetonitrile) and solvent B (50 mM ammonium
formate, pH 4.4). After the column was equilibrated using 30%
solvent B, the sample was injected and then eluted by a linear
gradient to 45% of solvent B for 60 min. HPLC analysis was
repeated more than three times.
Surface Plasmon Resonance Analysis
The surface plasmon resonance (SPR) analysis was performed
to confirm the affinity of mAbP CO17-1A to GA733 antigen
using a commercially available GLC chip on an XPR36 surface
instrument (Bio-Rad, Hercules, CA, USA). The GA733 protein
was immobilized on a GLC chip, and an acidic buffer at pH
6.0 was allowed to flow over the biochip surface at a rate of
50 µL/min. One microgram of the purified mAbP CO17-1A from
leaf and stem (0, 1, and 2 cycle samples) was dissolved in 300 µL
of 1× PBS, and the 300 µL was applied to immobilized receptors
with a flow rate of 50 µL/min at 25◦C and pH 6.0. After each
measurement, the surface of the sensor chip was regenerated
using phosphoric acid buffer.
RESULTS
Induction and Growth of Axillary Buds by
Bottom Stem Cut
Agrobacterium-mediated tobacco plant transformation was
conducted to generate transgenic plants expressing the anti-
colorectal cancer mAb CO17-1A (Ko et al., 2005; So et al., 2012).
The seeds of T2 transgenic plants were obtained by consecutive
self-fertilization of the T0 and T1 plants. Two well-expanded
true leaves appeared in the plantlets 21 days after sowing of T2
seeds. The growth period of the T2 plants until flower formation
was around 100 days (Figures 1A,B). The lateral shoot was
induced after retaining the root system by cutting the bottom
stem of transgenic plants expressing the anti-colorectal cancer
mAb CO17-1A (Figure 1A). Only a single lateral shoot was left
to grow until just before the floral organ formation (Figure 1A).
The bottom stem cutting was conducted in 2 cycles (Figure 1A).
However, the growth period of the axillary shoot to the flowering
stage from the cut stem was 30 and 35 days in the 1 and 2 cycles
(Figure 1B). Overall, the growth period of the lateral shoot in 1
and 2 cycles was almost three times shorter compared to that of
the primary shoot from the seedlings (0 cycle).
Existence of mAb CO17-1A HC and LC
Genes in 0, 1, and 2 Cycle Plants
The PCR analysis was conducted to confirm the existence of HC
and LC genes of mAb CO17-1A in the leaf and stem tissues
from top, middle, and base stem portions in 0, 1, and 2 cycles
(Figure 1C). The HC and LC genes existed in all the portions of
leaf and stem tissues of lateral shoot in all the cycles (Figure 1C).
No HC or LC gene was amplified in the samples from the
non-transgenic (NT) plants.
HC and LC Protein Levels of mAb
CO17-1A in the Leaf and Stem Tissues
from Top, Middle, and Base Portions
Through Recycling
The changes in HC and LC protein levels in top, middle, and
basal leaves and stems in 0, 1, and 2 cycles were investigated
by western blotting (Figures 1D,E). In the leaf tissue, the HC
and LC protein levels were stable over the cycles (Figure 1D left
and right panels, respectively). In the top leaves, the HC levels
slightly increased with the cycles. The LC levels were steady over
the cycles. In the stem tissue, the HC and LC levels were stable
over the cycles (Figure 1E left and right panels, respectively). In
the basal stems, the HC levels slightly decreased over the cycles
(Figure 1E left panel). Overall, the HC and LC protein levels were
similar in the samples from all the portions of stem through the
cycles.
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Glycan Analysis of mAbP CO17-1A
Purified from Leaf and Stem of 0, 1, and
2 Cycle Plants
The N-glycans of mAbP CO17-1A purified from the leaf and
stem of 0, 1, and 2 cycle plants were analyzed by HPLC. The
glycosylation patterns were analyzed in the leaf and stem (0, 1,
and 2 cycles) tissues (Figures 2A,B). The glycan profile of leaf
and stem from plants (0, 1 and 2 cycles) was similar and showed a
high mannose-type glycan structure profile. The percentages (%)
of oligomannose glycan in leaf and stem were ∼15 and ∼13.7–
14.9, respectively, through the cycles (Figures 2A,B). The glycan
structure profiles of mAbP CO17-1A in 0, 1, and 2 cycle plant
leaves and stems were similar.
SPR Analysis of mAb CO17-1A Purified from
Leaf and Stem of 0, 1, and 2 Cycle Plants
SDS-PAGE analysis was performed to identify the HC and
LC of the purified mAb CO17-1A in the plant leaf and stem
samples obtained in each cycle (0, 1, and 2; Data not shown).
The purified mAb CO17-1A from 0, 1, and 2 cycle plants
showed the same band sizes for HC and LC. Although the
cycle number increased, there was no change in the quality of
mAb CO17-1A, which remained undegraded. Expression and
purity of mAb CO17-1A in stems was also confirmed in 0, 1,
and 2 cycle plants. mAbP CO17-1A purified from the leaf and
stem samples of 0, 1 and 2 cycle plants were compared for
their binding activities (Figures 2C,D). All the mAbP CO17-1A
purified from leaf and stem tissues collected in different cycles
showed relatively similar interaction with the antigen GA733-
Fc using SPR (Figures 2C,D). The binding affinities of the mAb
CO17-1A purified from leaf and stem samples collected from
different cycle plants were similar except for the 2 cycle where the
mAb CO17-1A purified from stem (Figure 2D) showed slightly
higher affinity for the antigen than the mAb purified from the
leaf (Figure 2C). When the binding activities of mAb CO17-1A
purified from the leaf and stem samples were compared among
the cycles, the 1 cycle showed slightly lower affinity than the 0
FIGURE 2 | Glycosylation and function analyses of mAb CO17-1A protein purified from leaves and stem of 0, 1, and 2 cycle plants. (A,B) Profiles of
N-glycan from mAbP CO17-1A were analyzed using high performance liquid chromatography of the 2-AB labeled glycans. (A) Glycan structure profiles of mAbP
CO17-1A purified from leaf of 0, 1, and 2 cycle plants. (B) Glycan structure profiles of mAbP CO17-1A purified from stem of 0, 1, and 2 cycle plants. GlcNAc,
mannose, and xylose are depicted using black square, white circle, and white star, respectively. The ratios of oligomannose (white) and plant-specific (gray) glycans of
mAbP CO17-1A in leaves and stem of 0, 1, and 2 cycle plants were shown in a pie chart. Binding affinity of mAb CO17-1A purified from leaves (C) and stem (D) of 0,
1, and 2 cycle plants to GA733 antigen using surface plasmon resonance (SPR). Purified mAbP CO17-1AK from the leaves of 0, 1, and 2 cycle plants was incubated
with the GA733 adsorbed biochip (C). Purified mAbP CO17-1A from the stem of 0, 1, and 2 cycle plants was incubated with the GA733 adsorbed biochip (D).
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and 2 cycles (Figures 2C,D). In general, however, the peaks of
mAb CO17-A from both the leaf and stem samples were similar
between the 0 and 2 cycles.
DISCUSSION
In the present study, we demonstrate that fresh stem and
leaves regrow from axillary buds after cutting of the stem. The
lateral shoots, thus generated, could stably express functional
anti-colorectal cancer therapeutic antibody, mAb CO17-1A
recombinant protein, without alterations in its glycosylation
pattern.
The lateral shoots emerge from axillary meristems when the
apical dominance is removed (Leyser, 2003). In the present study,
the plants (1 and 2 cycles), induced to produce lateral branches
from the axillary buds, grew faster (∼30–35 days) to their full size
and flowered than the plants grown from the seedlings (0 cycle),
which required∼100 days to reach their full size.
In fact, the use of plant expression systems has been limited
due to longer growth period to obtain a full-sized plant with high
biomass (Hood et al., 2002; Horn et al., 2004; Teli and Timko,
2004). In our previous study, fully grown Nicotiana tabacum
plants started to form the floral organs at 12 weeks after sowing
(Lim et al., 2015), which is much longer than N. benthamiana
(7 weeks; Conley et al., 2011). N. benthamiana is another host
plant for production of recombinant proteins such as vaccine
and antibody, and has been established for their transient
expression (Gomez et al., 2013; Li et al., 2016). N. benthamiana
needs to be transfected every time with expression vector
inoculums to produce recombinant proteins. In addition, their
left over biomass should be properly discarded for avoiding
contamination, and the transfected plant can not be regrown for
further transfection usage. Thus, the transgenic plant regrowth by
axillary shoot induction with less than 4 weeks appears to be an
easy method to quickly increase the full biomass for production of
recombinant proteins even under limitations of space. Our results
suggest that axillary bud induction from the base stem with root
could be used in molecular biofarming strategies to overcome the
constraints of space and time.
The existence of HC and LC genes in both the leaves and stem
generated from the axillary buds during the regrowth cycles was
confirmed using PCR analysis, which revealed that the genes were
present in the top, middle, and basal portions of the leaves and
stem of the plants (0, 1, and 2 cycles) without any deletion.
The expression of HC and LC of mAb CO17-1A in the leaves
and stem from the top, middle, and basal positions obtained from
0, 1, and 2 cycle plants was confirmed by western blot. The HC
and LC expression rates were not significantly different among
the samples.
The mAb CO17-1A purified from the plants had a mainly
oligomannose structure profiles because of the C-terminus KDEL
signal tagging of HC for ER retention (So et al., 2012). The
glycosylation profiles were unmodified in leaf and stem in
samples from the 0, 1, and 2 cycles.
The mAb CO17-1A purified from primary (0 cycle), secondary
(1 cycle), and tertiary (2 cycle) plants showed similar binding
affinity to the GA733 antigen in SPR analysis. Leaves and stem
from the 1 cycle showed slightly lower binding activity than
those from the 0 and 2 cycle plants. However, it is speculated
that the slight fluctuation in the binding activity was due to the
variation in sample preparation, and not due to an actual loss
in the activity. The binding activities of mAb CO17-1A purified
from both the leaves and stem of plants from the same cycle were
similar. The results present notable evidence that plant recycling
can be applied for efficient biomass enhancement without any
variation in expression and function of the recombinant anti-
cancer therapeutic mAb. The rapid plant regrowth using by the
existing lateral buds in stem attached to the root is possible for
the plant biomass production in a limited space.
Taken together, the leaf and stem of the secondary and tertiary
cycles of plant growth (1 and 2 cycles) had similar mAb CO17-
1A expression rate, and the antigen affinity as well as glycan
structure profile of the purified mAb were comparable to the
purified mAb samples obtained from the primary plant growth
(0 cycle). This study shows that novel recycling plant system by
using regrowth from axillary buds can effectively circumvent the
space and time limitations for cultivation of plants. The strategy
of recycling plant production could be exploited for obtaining
increased transgenic plant biomass in less time and could be
useful for producing highly valuable recombinant proteins for
varied use.
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